Skip to main content
NIH funding notice PAR-22-059

Prodromal Synaptic and Circuit Changes that Contribute to AD/ADRD Onset and Progression (R01 Clinical Trial Not Allowed)

Closed on February 5, 2022.

Posted
November 3, 2021
Close date
February 5, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $4,758,381 in first-year total cost, median $2,379,191.

Most frequent study sections

  1. Cellular and Molecular Biology of Neurodegeneration Study Section[CMND]1
  2. Special Emphasis Panel[ZRG1 ETTN-Q (91)]1

Most frequent institutions

  1. UNIVERSITY OF WYOMING1
  2. YALE UNIVERSITY1
Competing awards under PAR-22-059 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2022Multimodal imaging of prodromal synaptic, circuit, and network-level dysfunction in a murine model of Alzheimer's disease1RF1NS130069-01CAI, ZHENGXINLAKE, EVELYN MRSTRITTMATTER, STEPHEN MTOYONAGA, TAKUYAYALE UNIVERSITY, CT$2,503,003ZRG1
2022Loss of TDP-43 disrupts the prefrontal neural activity and circuitry: relevance for TDP-43 linked ADRD1RF1NS129878-01LI, YUNWONG, PHILIP CUNIVERSITY OF WYOMING, WY$2,255,378CMND

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-22-059: Prodromal Synaptic and Circuit Changes that Contribute to AD/ADRD Onset and Progression (R01 Clinical Trial Not Allowed) | ScienceDex | ConductScience